Home Today's Paper Most Popular Video Gallery Photo Gallery
Subscription Blog Signin Register
Logo
Saturday, August 24, 2019 06:39:14 PM
Follow Us On: Facebook Twitter Twitter Twitter Twitter

Pioneering CAR-T cancer therapy

By
05th-Feb-2019       
Comments
Share your thought
Post a comment »
Read all () »

Fergus Walsh :
Yuvan Thakkar, who has a form of leukaemia, was given the personalised treatment at Great Ormond Street Hospital (GOSH), in London, after conventional cancer treatments failed.
CAR-T involves removing immune cells and modifying them in a laboratory so they can recognise cancer cells.
Previously, it was available only as part of a clinical research trial.
The CAR-T therapy, called Kymriah, costs £282,000 per patient, but the NHS has negotiated a undisclosed lower price with the manufacturer, Novartis. And the money will come from the Cancer Drugs Fund, set up to fast-track access to the most promising treatments.  
Kymriah is licensed to treat patients up to 25 years old with B-cell acute lymphoblastic leukaemia (ALL), for whom other treatments have failed.
NHS England announced in September that it would be funding the treatment, less than 10 days after it was granted a European licence. Yuvan, from Watford, was diagnosed with leukaemia in 2014. He received chemotherapy and then underwent a bone marrow transplant but relapsed after both treatments.
'Last hope'
Yuvan's parents, Sapna and Vinay, said: "When Yuvan was diagnosed, it was the most heartbreaking news we had ever received.
"We tried to stay hopeful, as they say leukaemia in children has 90% cure rate, but sadly his illness relapsed.
"This new therapy is our last hope."
Yuvan said: "I really hope I get better soon so I can visit Lego House in Denmark.
"I love Lego and am building a big model Bugatti while I'm in hospital."
Acute lymphoblastic leukaemia affects about 600 people a year, mostly children. Most are cured by conventional treatments but about 10% relapse.
In November, it was announced that GOSH, along with Royal Manchester Children's Hospital and Newcastle upon Tyne Hospitals NHS Foundation Trust, would treat children with this rare form of leukaemia.
Up to 30 patients a year are expected to be treated.
CAR-T is a truly personalised form of cancer treatment.
First, the patient has blood removed and the white blood cells are separated out, with the rest of the blood being returned to the patient.
The T-cells, a special type of immune cell, are then sent to a laboratory in the United States, where a harmless virus is used to insert genes into them.
These genes cause the T-cells to add a hook on to their surface, known as a chimeric antigen receptor (CAR).
These engineered CAR-T cells - programmed to recognise and destroy the patient's cancer cells - are multiplied in huge numbers and then infused back into the patient.
Possible side-effects
Tuvan had his immune cells removed in November and the engineered T-cells were infused last week.
Dr Sara Ghorashian, consultant in paediatric haematology at GOSH and Yuvan's doctor, said: "We are so pleased to be able to offer patients like Yuvan another chance to be cured.
"While it will be a while before the outcome of this powerful new therapy is known, the treatment has shown very promising results in clinical trials and we are hopeful that it will help."
Royal Manchester Children's Hospital has also begun treating their first patient with the personalised Kymriah immunotherapy.
The 11-year-old girl, from Liverpool, is expected to have her modified CAR-T cells infused in a few weeks.
In a clinical trial of 75 patients for whom all other treatments had failed, half were still in complete remission after a year.
However, there were some serious side-effects, with some patients needing intensive care due to cytokine-release syndrome.
This can cause fever, low blood pressure and difficulty breathing but can be treated in most patients.
CAR-T for adults
NHS England has also agreed to fund another CAR-T therapy for adults with lymphoma.
The treatment, Yescarta, would have cost nearly £300,000 per patient but Gilead Sciences has agreed a lower price.
Up to 200 patients a year will be eligible.
(Fergus Walsh is Medical Correspondent, BBC).

Tariff
Add Rate

News Archive

Inside The New Nation

Editorial »

We cannot repatriate Rohingyas without UN supervision


NO Rohingya refugees were repatriated till Thursday noon as none of them showed "willingness" to return to Myanmar. In a fresh attempt, 3,450 Rohingya people were scheduled to be repatriated to Myanmar. Before any repatriation takes place, refugees are taken to transit camps and kept there for two to three ...

Entertainment »

Chanchal, Mamo as pair can attract the viewers in film


Sheikh Arif Bulbon :In last Eid, National Film Award winner two actors Chanchal Chowdhury and Zakia Bari Mamo-starred three dramas were telecasted in different TV channels. These dramas are: SA Haque Alik’s Sorry Bolo, Sokal Ahmed’s Byaktitto Babul and Ratan Hasan’s Nobboi Din. They got the viewers attention to play ...

International »

Macron backs more Brexit talks but insists no concessions


AFP, Paris :French President Emmanuel Macron on Thursday backed holding further talks to avoid Britain crashing out of the EU without a deal but rejected major concessions, as he hosted Prime Minister Boris Johnson just over two months ahead of the planned British exit.Echoing comments by German Chancellor Angela Merkel, ...

Entertainment »

Radhika Apte has given us character to remember forever


Indie Star Radhika Apte became the talk of the town for her earthy and unconventional character. It was the actress’ character from Manjhi: The Mountain Man which made us all believe in how chaos in beautiful and garnered appreciation from all across. Celebrating the highly critically acclaimed film, Radhika is ...

Editorial »

ACC fails to gain trust of common people


THE 11 ACC officials whose faulty and biased investigation led to wrongful imprisonment of Jaha Alam for three years have been promoted to senior ranks. Even the Anti-Corruption Commission's (ACC) own investigation acknowledged that Jaha Alam had to lose three years of his life in prison because these officials "erroneously ...

Cricket »

Afghanistan Test a preparation platform for Indian series: Mominul


Bangladesh will take the one-off Test match against Afghanistan as part of their preparation for the two-match Test series against India, with which they will begin the journey of ICC World Test Championship.As India is blessed with some world class spinners who could demolish any side at their home den, ...

International »

Putin says US missile test raises new threats to Russia


AP, Helsinki :Russian President Vladimir Putin said Wednesday that the test of a new U.S. missile banned under a now-defunct arms treaty has raised new threats to Russia and will warrant a response.The U.S. tested a modified ground-launched version of a Navy Tomahawk cruise missile that accurately struck its target ...

Editorial »

Muhith can't be blamed, he is part of the system


National Board of Revenue has allowed former finance minister AMA Muhith to release an imported car under the duty-free scheme meant for the Members of Parliament. The NBR on Monday issued a special order exempting Muhith from payment of all types of import duty, value-added tax and supplementary duty to ...

Editorial »

We have to see positive results in our relations with India


INDIAN External Affairs Minister S Jaishankar on Monday reconfirmed his government's stance on most-hyped Teesta water-sharing treaty that remained "unchanged" and "mutually acceptable formula" for sharing water of 54 common rivers. The three-day visit of the top Indian envoy has taken place at a time when the Indian government is ...

Football »

Ribery set for two-year deal at Fiorentina pending medical


Franck Ribery has landed in Florence and will undergo a medical ahead of completing a free transfer to Fiorentina.The 36-year-old left Bayern Munich in June after 12 years at the club and will now sign a two-year deal with the Serie A side worth almost £4.1m (€4.5m) per season, according ...

Entertainment »

Swastika shuts down malicious troll like a boss


As we say, ‘no one is perfect,’ the myth of ‘perfect body’ is quite a tough role to live up to and our silver screen celebrities have always been under a constant surveillance of the hypocritical body shamers. For even an ounce of extra weight gain or a shred from ...

International »

Johnson, Merkel to face off in first Brexit talks


AFP, Berlin :British Prime Minister Boris Johnson visits Berlin on Wednesday to kick off a marathon of tense talks with key European and international leaders as the threat of a chaotic no-deal Brexit looms.On his first foreign visit since taking office, he will seek to convince German Chancellor Angela Merkel, ...

International »

US ready to resume nuclear talks with North Korea


AFP, Seoul : The United States is ready to sit down with North Korea to resume long-awaited working-level nuclear talks, a US envoy said on Wednesday.Nuclear discussions between Washington and Pyongyang have stalled since a second summit in Hanoi in February ended without an agreement over differences on the extent of ...

Editorial »

DCCs' dengue drama


AS Bangladesh, especially the capital is reeling under massive dengue outbreak, mobile courts run by Dhaka's two city corporations are penalising the residents keeping public places and government establishments hosting aedes mosquito breeding grounds out of purview.Dengue has already claimed at least 113 lives and at least 55,000 dengue patients ...

Cricket »

'Frightening' Archer won't let-up against Australia, says Stokes


England's Ben Stokes has told Australia to expect more bouncers from Jofra Archer in the remainder of the Ashes."It's part of the game and a big part of Jofra's game, being aggressive, not letting batsmen settle," said Stokes.World Cup-winning fast bowler Archer produced a hostile and compelling display on debut ...

 
Items that you save may be read at any time on your computer, iPad, iPhone or Android devices.
 
Are you new to our website? Do you have already an account at our website?
Create An Account Log in here
Email this news to a friend or like someone
Email:
Write a comment to this news